Select Medical (NYSE:SEM) Upgraded at StockNews.com

StockNews.com upgraded shares of Select Medical (NYSE:SEM) from a hold rating to a buy rating in a report released on Tuesday morning.

Several other analysts have also issued reports on SEM. Royal Bank of Canada boosted their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Finally, UBS Group reduced their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $39.50.

Select Medical Trading Up 0.6 %

Shares of SEM stock opened at $18.75 on Tuesday. Select Medical has a 12-month low of $18.02 and a 12-month high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The company has a 50 day moving average of $26.06 and a 200-day moving average of $31.88. The firm has a market cap of $2.43 billion, a P/E ratio of 8.76, a PEG ratio of 0.39 and a beta of 1.45.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period in the previous year, the company posted $0.46 earnings per share. The business’s revenue was up 5.7% on a year-over-year basis. Sell-side analysts anticipate that Select Medical will post 1.97 earnings per share for the current year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were issued a $0.125 dividend. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 annualized dividend and a dividend yield of 2.67%. Select Medical’s payout ratio is currently 23.36%.

Insider Buying and Selling

In other news, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. The trade was a 59.26 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. This represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is owned by company insiders.

Institutional Trading of Select Medical

A number of hedge funds have recently bought and sold shares of SEM. Dimensional Fund Advisors LP grew its stake in shares of Select Medical by 2.2% during the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock valued at $157,728,000 after buying an additional 95,578 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Select Medical by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after acquiring an additional 46,880 shares during the period. Principal Financial Group Inc. grew its position in Select Medical by 6.7% during the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after acquiring an additional 147,032 shares during the last quarter. Point72 Asset Management L.P. increased its stake in Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after purchasing an additional 1,216,263 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in Select Medical by 1.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock valued at $57,407,000 after purchasing an additional 24,439 shares during the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.